ReviewFrontiers in oncology2021

Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress.

Yaning Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.